Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines-Reference-Cited by-同舟云学术

Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines

Published:2019-10 Issue: Volume:461 Page:90-101
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Marampon Francesco,Di Nisio Valentina,Pietrantoni Ilaria,Petragnano Francesco,Fasciani Irene,Scicchitano Bianca Maria,Ciccarelli Carmela,Gravina Giovanni Luca,Festuccia Claudio,Del Fattore Andrea,Tombolini Mario,De Felice Francesca,Musio Daniela,Cecconi Sandra,Tini Paolo,Maddalo Marta,Codenotti Silvia,Fanzani Alessandro^ORCID,Polimeni Antonella,Maggio Roberto^ORCID,Tombolini Vincenzo

Funder

“FIVA Confcommercio” and University of Rome, Sapienza

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference53 articles.

1. Rhabdomyosarcoma

2. Treatment approach and outcomes in infants with localized rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group;Bradley;Int. J. Radiat. Oncol. Biol. Phys.,2019

3. Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study;Bompas;Cancer Med,2018

4. The role of radiation therapy in the management of sarcomas;Kaushal;Surg. Clin. N. Am.,2008

5. New insights into signalling-pathway alterations in rhabdomyosarcoma;Zhu;Br. J. Canc.,2015

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks;Cell Death Discovery;2024-08-06

2. Contemporary preclinical mouse models for pediatric rhabdomyosarcoma: from bedside to bench to bedside;Frontiers in Oncology;2024-02-02

3. DNA repair in tumor radioresistance: insights from fruit flies genetics;Cellular Oncology;2023-12-14

4. Complexation of histone deacetylase inhibitor belinostat to Cu(II) prevents premature metabolic inactivation in vitro and demonstrates potent anti-cancer activity in vitro and ex vivo in colon cancer;Cellular Oncology;2023-11-07

5. A Novel High-Content Screening Assay Identified Belinostat as Protective in a FSGS—Like Zebrafish Model;Journal of the American Society of Nephrology;2023-09-27